AACR conference examines how societal framework of racism drives cancer disparities

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

The global coronavirus pandemic has torn the veil that dimmed the nation’s awareness of the breadth and depth of health disparities, including cancer health disparities.

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe
Steven R. Patierno, PhD
Deputy director, Duke Cancer Institute; Professor of medicine, pharmacology and cancer biology, professor of family medicine and community health, Duke University School Medicine; Conference co-chair, AACR Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved

YOU MAY BE INTERESTED IN

In 1971, the National Cancer Act set the United States on a path to confront one of its most formidable public health challenges. More than five decades later, the progress is undeniable. The latest 2026 report from the American Cancer Society shows continued declines in overall cancer mortality and improvements in survival for many major cancer types. Recent advances in early detection, prevention, and treatment are saving lives.
Steven R. Patierno, PhD
Deputy director, Duke Cancer Institute; Professor of medicine, pharmacology and cancer biology, professor of family medicine and community health, Duke University School Medicine; Conference co-chair, AACR Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login